Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Dare Bioscience, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 25 | 27 | +2 |
| Shares | 1.02M | 1.30M | +276.9K (+27.0%) |
| Value | $1.87M | $2.75M | +$881.9K (+47.3%) |
New holders (7)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 36,092 | $76.2K | 0.00% |
| HRT Financial LP | 22,430 | $47.0K | 0.00% |
| Virtu Financial LLC | 15,803 | $33.0K | 0.00% |
| StoneX Group Inc. | 11,153 | $24.7K | 0.00% |
| Bay Harbor Wealth Management, LLC | 1,358 | $2.87K | 0.00% |
| Jones Financial Companies LLLP | 396 | $828 | 0.00% |
| Barclays PLC | 248 | $523 | 0.00% |
Sold out (5)
Institutions that held Dare Bioscience, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| XTX Topco Ltd | 22,339 | $40.7K |
| Susquehanna International Group, LLP | 17,130 | $31.2K |
| Two Sigma Investments, LP | 13,279 | $24.2K |
| Renaissance Technologies LLC | 10,195 | $18.6K |
| Royal Bank of Canada | 59 | $0 |